At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 58 target
Drug / intervention
Gastrografin +1 moredrug
Likely dose
Gastrografin 100 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Randomized Double Blind Study of the Effect of Gastrografin on Postoperative Ileus After Colorectal Surgery
In Brief
A Phase 4 clinical trial evaluating Gastrografin and physiological serum for Postoperative Ileus. Completed, enrolled 58 participants across 3 sites.
Detailed Summary
The purpose of this trial is to determine whether the water-soluble contrast (gastrografin) is more effective in the treatment of postoperative ileus than the conventional one.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Ileus
CountriesSpain
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 2011
Enrollment StartDec 2011
Primary CompletionNov 2013
Study CompletionDec 2013
TodayJul 2026
First PostedSep 26, 2011
Enrollment StartDec 1, 2011
Primary CompletionNov 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 14.8 years ago
Interventions
Gastrografindrug
Administration of 100 ml of gastrografin by the nasogastric tube, only once.
physiological serumdrug
Administration of 100 ml of physiological serum 0,9% by the nasogastric tube, only once.